T
EHC icon

Transce3nd’s Encompass Health EHC Stock Holding History

Transce3nd’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-171
Closed -$21K – 434
2025
Q2 		$21K Sell
171
-102
-37% -$11.7K 0.01% 439
2025
Q1 		$27.6K Sell
273
-165
-38% -$16.1K 0.01% 380
2024
Q4 		$40.4K Buy
+438
New +$43K 0.01% 418

Other funds holding EHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Transce3nd's EHC Position: Q3 2025 in Review

Transce3nd sold out of Encompass Health (EHC) in Q3 2025, closing a stake of 171 shares — an estimated $21K sold.

Transce3nd first reported a position in EHC in Q4 2024 and held it in 3 quarters. The position peaked at $40.4K in Q4 2024. 604 funds tracked by Wall St. Rank hold EHC as of Q3 2025.

  • Transce3nd reported no remaining Encompass Health position as of Q3 2025 after selling out during the quarter.
  • Transce3nd sold 171 Encompass Health shares in Q3 2025, an estimated $21K.
  • Transce3nd first reported a position in Encompass Health in Q4 2024 and held it in 3 quarters.
  • Transce3nd's Encompass Health position peaked at $40.4K in Q4 2024.
  • 604 funds tracked by Wall St. Rank held Encompass Health as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.